BRNS
Barinthus Biotherapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.74
−2.49%Sep 24, 2026, 13:21 UTC
Beacon Topco, Inc. amended its merger agreement with Barinthus Biotherapeutics plc, Cdog Merger Sub, Inc. and Clywedog Therapeutics, Inc., setting the closing date and the 'End Date' at October 31, 2026.
Aug 25, 2026, 00:00 UTC
Barinthus Biotherapeutics plc transferred its listing from NASDAQ to another exchange, as disclosed in an 8-K filing on August 24, 2026.
Aug 6, 2026, 12:00 UTC
Barinthus Biotherapeutics plc completed enrollment of 42 planned subjects in the Phase 1 AVALON trial evaluating VTP-1000 in patients with celiac disease.
Source:Aug 6, 2026, 12:00 UTC
Barinthus Biotherapeutics plc announced that its proposed combination with Clywedog Therapeutics Inc. is progressing towards closing.
Aug 6, 2026, 12:00 UTC
Barinthus Biotherapeutics plc reported its financial results for the quarter ended June 30, 2026.
Source: